Ali Khademhosseini, PhD



Ali Khademhosseini received his Ph.D. in bioengineering from MIT in 2005 under the supervision of Professor Robert Langer. He then began his independent career at Harvard University where he rose to Professor at Harvard Medical School (HMS) and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST), Brigham and Women’s Hospital (BWH) and as well as associate faculty at the Wyss Institute for Biologically Inspired Engineering. As of November 2017, he is the Levi Knight Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). He is the Founding Director of the Center for Minimally Invasive Therapeutics at UCLA as well as an Associate Director of the California NanoSystems Insitute. He is a leader in applying bioengineering solutions to precision medicine. His large and interdisciplinary group is interested in developing ‘personalized’ solutions that utilize micro- and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease and cancer. He has edited multiple books / journal special issues and is an author on >500 peer-reviewed journal articles, editorials and review papers, >60 book chapters/edited books and >20 patent/disclosure applications. His work has been published in leading journals and routinely highlighted in international media. Dr. Khademhosseini is an Associate Editor for ACS Nano. He has been cited >38,000 times and has an H-index of 99. Find out more about Ali Khademhosseini.